KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $936.8 million.

  • Astrana Health's Operating Expenses rose 10805.45% to $936.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 7315.52%. This contributed to the annual value of $1.9 billion for FY2024, which is 4939.46% up from last year.
  • Latest data reveals that Astrana Health reported Operating Expenses of $936.8 million as of Q3 2025, which was up 10805.45% from $634.5 million recorded in Q2 2025.
  • Over the past 5 years, Astrana Health's Operating Expenses peaked at $936.8 million during Q3 2025, and registered a low of $154.3 million during Q1 2021.
  • Its 5-year average for Operating Expenses is $375.5 million, with a median of $314.9 million in 2023.
  • Per our database at Business Quant, Astrana Health's Operating Expenses crashed by 402.08% in 2021 and then surged by 10805.45% in 2025.
  • Quarter analysis of 5 years shows Astrana Health's Operating Expenses stood at $192.9 million in 2021, then surged by 46.03% to $281.6 million in 2022, then increased by 26.73% to $356.9 million in 2023, then soared by 86.18% to $664.5 million in 2024, then soared by 40.99% to $936.8 million in 2025.
  • Its Operating Expenses stands at $936.8 million for Q3 2025, versus $634.5 million for Q2 2025 and $599.8 million for Q1 2025.